Potential Therapeutic Effects of NAMPT-Mediated NAD Biosynthesis in Depression In Vivo
Abstract
:1. Introduction
2. Materials and Methods
2.1. Animals
2.2. Treatment Groups
2.3. Chronic Unpredictable Mild Stress (CUMS)
2.4. Sucrose Preference Test (SPT)
2.5. Open Field Test (OFT)
2.6. Elevated Plus Maze (EPM)
2.7. Novel Object Recognition Test (NORT)
2.8. Dominance Tube Test (DTT)
2.9. Social Interaction Test (SIT)
2.10. Tail Suspension Test (TST)
2.11. Forced Swimming Test (FST)
2.12. BDNF, CREB, pCREB, and NAMPT Expression in the PFC and HIP
2.13. Detection of NAD, CORT, DA, 5-HT, and NE Levels
2.14. Statistical Methods
3. Results
3.1. NAMPT-NAD-CREB Expression in Namptflox/flox Mice and Behavioral Changes
3.1.1. NAMPT-NAD Expression Is Decreased in PFC in Namptflox/flox Mice
3.1.2. Reduction in Locomotor Activity and Depression-Like Behavior in Namptflox/flox Mice
3.1.3. Reduction in Social Behaviors, Cognitive Function, and Social Dominant Position in Namptflox/flox Mice
3.1.4. Levels of BDNF-CREB and Monoamine Neurotransmitters Changed in the Prefrontal Cortex in Namptflox/flox Mice
3.2. Effects of NR on Depression in Rats
3.2.1. Levels of NAMPT and NAD in PFC and HIP with NR Treatment in CUMS-induced Depression Rats
3.2.2. Amelioration of Depression- and Anxiety-Associated Behavior with NR Treatment in CUMS-Induced Depression Rats
3.2.3. Improvement of Locomotor Activity and Cognitive Function with NR Treatment in CUMS-Induced Depression Rats
3.2.4. Levels of BDNF, pCREB/CREB, CORT, DA, and 5-HT in the PFC or HIP with NR Treatment in CUMS-Induced Depression Rats
4. Discussion
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Asokan, G.V.; Awadhalla, M.; Albalushi, A.; Al-Tamji, S.; Juma, Z.; Alasfoor, M.; Gayathripriya, N. The magnitude and correlates of geriatric depression using Geriatric Depression Scale (GDS-15)—A Bahrain perspective for the WHO 2017 campaign ‘Depression—Let’s talk’. Perspect. Public Health 2019, 139, 79–87. [Google Scholar] [CrossRef] [PubMed]
- Park, S.W.; Kim, Y.K.; Lee, J.G.; Kim, S.H.; Kim, J.M.; Yoon, J.S.; Park, Y.K.; Lee, Y.K.; Kim, Y.H. Antidepressant-like effects of the traditional Chinese medicine kami-shoyo-san in rats. Psychiatry Clin. Neurosci. 2007, 61, 401–406. [Google Scholar] [CrossRef] [PubMed]
- Pizzagalli, D.A.; Roberts, A.C. Prefrontal cortex and depression. Neuropsychopharmacology 2022, 47, 225–246. [Google Scholar] [CrossRef] [PubMed]
- Hare, B.D.; Duman, R.S. Prefrontal cortex circuits in depression and anxiety: Contribution of discrete neuronal populations and target regions. Mol. Psychiatry 2020, 25, 2742–2758. [Google Scholar] [CrossRef]
- Głombik, K.; Detka, J.; Kurek, A.; Budziszewska, B. Impaired brain energy metabolism: Involvement in depression and hypothyroidism. Front. Neurosci. 2020, 14, 586939. [Google Scholar] [CrossRef]
- Xie, N.; Zhang, L.; Gao, W.; Huang, C.; Huber, P.E.; Zhou, X.; Li, C.; Shen, G.; Zou, B. NAD+ metabolism: Pathophysiologic mechanisms and therapeutic potential. Signal Transduct. Target. Ther. 2020, 5, 227. [Google Scholar] [CrossRef]
- Mendelsohn, A.R.; Larrick, J.W. The NAD+/PARP1/SIRT1 axis in aging. Rejuvenation Res. 2017, 20, 244–247. [Google Scholar] [CrossRef]
- Covarrubias, A.J.; Perrone, R.; Grozio, A.; Verdin, E. NAD+ metabolism and its roles in cellular processes during ageing. Nat. Rev. Mol. Cell Biol. 2021, 22, 119–141. [Google Scholar] [CrossRef]
- Revollo, J.R.; Grimm, A.A.; Imai, S. The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells. J. Biol. Chem. 2004, 279, 50754–50763. [Google Scholar] [CrossRef] [Green Version]
- Rajman, L.; Chwalek, K.; Sinclair, D.A. Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence. Cell Metab. 2018, 27, 529–547. [Google Scholar] [CrossRef]
- Imai, S. Dissecting systemic control of metabolism and aging in the NAD World: The importance of SIRT1 and NAMPT-mediated NAD biosynthesis. FEBS Lett. 2011, 585, 1657–1662. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Yaku, K.; Okabe, K.; Nakagawa, T. NAD metabolism: Implications in aging and longevity. Ageing Res. Rev. 2018, 47, 1–17. [Google Scholar] [CrossRef]
- Ye, K.; Yao, S.; Wang, R.; Fang, Z.; Zhong, K.; Nie, L. PI3K/Akt/NF-kappaB signaling pathway regulates behaviors in adolescent female rats following with neonatal maternal deprivation and chronic mild stress. Behav. Brain Res. 2019, 362, 199–207. [Google Scholar] [CrossRef] [PubMed]
- Park, M.J.; Seo, B.A.; Lee, B.; Shin, H.S.; Kang, M.G. Stress-induced changes in social dominance are scaled by AMPA-type glutamate receptor phosphorylation in the medial prefrontal cortex. Sci. Rep. 2018, 8, 15008. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Cao, W.Y.; Hu, Z.L.; Xu, Y.; Zhang, W.J.; Huang, F.L.; Qiao, X.Q.; Cui, Y.H.; Wan, W.; Wang, X.Q.; Liu, D.; et al. Role of early environmental enrichment on the social dominance tube test at adulthood in the rat. Psychopharmacology 2017, 234, 3321–3334. [Google Scholar] [CrossRef]
- Kim, S.; Lee, B.; Choi, J.H.; Kim, J.H.; Kim, C.H.; Shin, H.S. Deficiency of a brain-specific chemokine-like molecule, SAM3, induces cardinal phenotypes of autism spectrum disorders in mice. Sci. Rep. 2017, 7, 16503. [Google Scholar] [CrossRef] [Green Version]
- Duman, R.S.; Sanacora, G.; Krystal, J.H. Altered connectivity in depression: GABA and glutamate neurotransmitter deficits and reversal by novel treatments. Neuron 2019, 102, 75–90. [Google Scholar] [CrossRef]
- Huang, P.; Gao, T.; Dong, Z.; Zhou, C.; Lai, Y.; Pan, T.; Liu, Y.; Zhao, X.; Sun, X.; Hua, H.; et al. Neural circuitry among connecting the hippocampus, prefrontal cortex and basolateral amygdala in a mouse depression model: Associations correlations between BDNF levels and BOLD-fMRI signals. Brain Res. Bull. 2018, 142, 107–115. [Google Scholar] [CrossRef]
- Tannous, C.; Booz, G.W.; Altara, R.; Muhieddine, D.H.; Mericskay, M.; Refaat, M.M.; Zouein, F.A. Nicotinamide adenine dinucleotide: Biosynthesis, consumption and therapeutic role in cardiac diseases. Acta Physiol. 2021, 231, e13551. [Google Scholar] [CrossRef]
- Liu, Z.; Li, C.; Fan, X.; Kuang, Y.; Zhang, X.; Chen, L.; Song, J.; Zhou, Y.; Takahashi, E.; He, G.; et al. Nicotinamide, a vitamin B3 ameliorates depressive behaviors independent of SIRT1 activity in mice. Mol. Brain 2020, 13, 162. [Google Scholar] [CrossRef]
- Kim, H.D.; Hesterman, J.; Call, T.; Magazu, S.; Keeley, E.; Armenta, K.; Kronman, H.; Neve, R.L.; Nestler, E.J.; Ferguson, D. SIRT1 mediates depression-like behaviors in the nucleus accumbens. J. Neurosci. 2016, 36, 8441–8452. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lautrup, S.; Sinclair, D.A.; Mattson, M.P.; Fang, E.F. NAD+ in Brain Aging and Neurodegenerative Disorders. Cell Metab. 2019, 30, 630–655. [Google Scholar] [CrossRef] [PubMed]
- Lin, J.B.; Kubota, S.; Ban, N.; Yoshida, M.; Santeford, A.; Sene, A.; Nakamura, R.; Zapata, N.; Kubota, M.; Tsubota, K.; et al. NAMPT-mediated NAD(+) biosynthesis is essential for vision in mice. Cell Rep. 2016, 17, 69–85. [Google Scholar] [CrossRef] [Green Version]
- Imai, S.; Guarente, L. NAD+ and sirtuins in aging and disease. Trends Cell Biol. 2014, 24, 464–471. [Google Scholar] [CrossRef]
- Trammell, S.A.; Schmidt, M.S.; Weidemann, B.J.; Redpath, P.; Jaksch, F.; Dellinger, R.W.; Li, Z.; Abel, E.D.; Migaud, M.E.; Brenner, C. Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nat. Commun. 2016, 7, 12948. [Google Scholar] [CrossRef] [Green Version]
- Pizzagalli, D.A. Depression, stress, and anhedonia: Toward a synthesis and integrated model. Annu. Rev. Clin. Psychol. 2014, 10, 393–423. [Google Scholar] [CrossRef] [Green Version]
- Kanekar, S.; Sheth, C.; Ombach, H.; Brown, J.; Hoffman, M.; Ettaro, R.; Renshaw, P. Sex-based changes in rat brain serotonin and behavior in a model of altitude-related vulnerability to treatment-resistant depression. Psychopharmacology 2021, 238, 2867–2881. [Google Scholar] [CrossRef]
- Chang, J.; Zhang, B.; Heath, H.; Galjart, N.; Wang, X.; Milbrandt, J. Nicotinamide adenine dinucleotide (NAD)-regulated DNA methylation alters CCCTC-binding factor (CTCF)/cohesin binding and transcription at the BDNF locus. Proc. Natl. Acad. Sci. USA 2010, 107, 21836–21841. [Google Scholar] [CrossRef] [Green Version]
- Li, J.; He, P.; Zhang, J.; Li, N. Orcinol glucoside improves the depressive-like behaviors of perimenopausal depression mice through modulating activity of hypothalamic-pituitary-adrenal/ovary axis and activating BDNF- TrkB-CREB signaling pathway. Phytother. Res. 2021, 35, 5795–5807. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Wang, J.; Sun, R.; Xia, L.; Zhu, X.; Zhang, Q.; Ye, Y. Potential Therapeutic Effects of NAMPT-Mediated NAD Biosynthesis in Depression In Vivo. Brain Sci. 2022, 12, 1699. https://doi.org/10.3390/brainsci12121699
Wang J, Sun R, Xia L, Zhu X, Zhang Q, Ye Y. Potential Therapeutic Effects of NAMPT-Mediated NAD Biosynthesis in Depression In Vivo. Brain Sciences. 2022; 12(12):1699. https://doi.org/10.3390/brainsci12121699
Chicago/Turabian StyleWang, Jue, Runxuan Sun, Linhan Xia, Xinying Zhu, Qi Zhang, and Yilu Ye. 2022. "Potential Therapeutic Effects of NAMPT-Mediated NAD Biosynthesis in Depression In Vivo" Brain Sciences 12, no. 12: 1699. https://doi.org/10.3390/brainsci12121699